APA (7th ed.) Citation

ZC, W., C, L., Z, Z., S, L., YM, L., P, Q., . . . PF, G. (2025). Targeting PPARα activation sensitizes glioblastoma cells to temozolomide and reverses acquired resistance by inhibiting H3K18 lactylation. Acta pharmacologica Sinica, 46(11), 3071. https://doi.org/10.1038/s41401-025-01600-z

Chicago Style (17th ed.) Citation

ZC, Wang, et al. "Targeting PPARα Activation Sensitizes Glioblastoma Cells to Temozolomide and Reverses Acquired Resistance by Inhibiting H3K18 Lactylation." Acta Pharmacologica Sinica 46, no. 11 (2025): 3071. https://doi.org/10.1038/s41401-025-01600-z.

MLA (9th ed.) Citation

ZC, Wang, et al. "Targeting PPARα Activation Sensitizes Glioblastoma Cells to Temozolomide and Reverses Acquired Resistance by Inhibiting H3K18 Lactylation." Acta Pharmacologica Sinica, vol. 46, no. 11, 2025, p. 3071, https://doi.org/10.1038/s41401-025-01600-z.